Sensus Healthcare (SRTS) Stock Overview
Operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
SRTS Community Fair Values
Create NarrativeSee what 102 others think this stock is worth. Follow their fair value or set your own to get alerts.
SRTS Market Outlook
Sensus Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.34 |
| 52 Week High | US$9.33 |
| 52 Week Low | US$3.03 |
| Beta | 1.39 |
| 1 Month Change | 7.74% |
| 3 Month Change | -37.22% |
| 1 Year Change | -47.57% |
| 3 Year Change | -76.13% |
| 5 Year Change | 34.68% |
| Change since IPO | -42.91% |
Recent News & Updates
Recent updates
Insufficient Growth At Sensus Healthcare, Inc. (NASDAQ:SRTS) Hampers Share Price
Oct 04
Returns On Capital Are Showing Encouraging Signs At Sensus Healthcare (NASDAQ:SRTS)
Jul 12Why Sensus Healthcare, Inc. (NASDAQ:SRTS) Could Be Worth Watching
May 06Investors Shouldn't Be Too Comfortable With Sensus Healthcare's (NASDAQ:SRTS) Earnings
Mar 13Sensus Healthcare, Inc. (NASDAQ:SRTS) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Feb 25Revenue Beat: Sensus Healthcare, Inc. Beat Analyst Estimates By 5.6%
Feb 08SRTS Market Outlook
Sensus Healthcare (NASDAQ: SRTS) operates in the Healthcare sector and is part of the Medical Devices industry. Specifically, it focuses on the development and commercialization of non-invasive SuperfWe Think Sensus Healthcare (NASDAQ:SRTS) Might Have The DNA Of A Multi-Bagger
Dec 18Results: Sensus Healthcare, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 19Sensus Healthcare, Inc. (NASDAQ:SRTS) Doing What It Can To Lift Shares
Nov 12At US$6.10, Is It Time To Put Sensus Healthcare, Inc. (NASDAQ:SRTS) On Your Watch List?
Oct 03
Fair Deal Agreement And Global Expansion Set To Revolutionize Revenue And Margins
Strategic shift towards recurring revenue with the Fair Deal Agreement model indicates potential for significant revenue growth from 2025.Returns At Sensus Healthcare (NASDAQ:SRTS) Are On The Way Up
May 12Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk
Apr 16Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital
Oct 17Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger
Jul 04Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop
Mar 14Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?
Mar 06Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger
Oct 11Shareholder Returns
| SRTS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 4.4% | 3.2% | 2.0% |
| 1Y | -47.6% | 2.4% | 17.9% |
Return vs Industry: SRTS underperformed the US Medical Equipment industry which returned 2.4% over the past year.
Return vs Market: SRTS underperformed the US Market which returned 17.9% over the past year.
Price Volatility
| SRTS volatility | |
|---|---|
| SRTS Average Weekly Movement | 11.6% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SRTS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: SRTS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 54 | Joe Sardano | sensushealthcare.com |
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
Sensus Healthcare, Inc. Fundamentals Summary
| SRTS fundamental statistics | |
|---|---|
| Market cap | US$54.91m |
| Earnings (TTM) | -US$848.00k |
| Revenue (TTM) | US$37.56m |
Is SRTS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SRTS income statement (TTM) | |
|---|---|
| Revenue | US$37.56m |
| Cost of Revenue | US$17.96m |
| Gross Profit | US$19.60m |
| Other Expenses | US$20.45m |
| Earnings | -US$848.00k |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 06, 2025
| Earnings per share (EPS) | -0.052 |
| Gross Margin | 52.18% |
| Net Profit Margin | -2.26% |
| Debt/Equity Ratio | 0% |
How did SRTS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/26 17:35 |
| End of Day Share Price | 2025/10/24 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sensus Healthcare, Inc. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew D'Silva | B. Riley Securities, Inc. |
| Alexander Nowak | Craig-Hallum Capital Group LLC |
| Vadim Merkulov | Freedom Broker |